Tus-Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 148.513 million compared to CNY 115.156 million a year ago. Operating income was CNY 33.676 million compared to CNY 16.223 million a year ago. Net income was CNY 29.199 million compared to CNY 13.834 million a year ago. Basic earnings per share from continuing operations was CNY 0.1219 compared to CNY 0.0578 a year ago.